ASHTON WILLIAM enters MEDICUS PHARMA LTD. with 1.25K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 12/31/2024ACC: 0000950142-24-003030
1.25K
Baseline shares
100% direct
1.25K
Direct ownership
1 position
25K
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Common Shares, no par value ("Common Shares")
DirectShares owned1.25K
Total
1.25K direct1.25K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Shares, no par value ("Common Shares") | 1.25K | Direct |
| Total | 1.25K | 1.25K direct |
Derivative Holdings1
Stock Option (right to buy)
DirectUnderlying security
Common Shares
Underlying shares
25K
Shares owned
N/A
Exercise price
0.81
Expiration
—
Exercise window
—
Total
Underlying
25K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Shares | 0.81 | — | — | 25K | N/A |
| Total | 25K | 0.00 | ||||